Learn more about our Diabetes work.
WASHINGTON—AdvaMed, the MedTech Association®, today announced that Jacob “Jake” Leach, President and Chief Executive Officer at Dexcom, will serve as the next chair of theAdvaMed® Diabetes Sector, succeeding Chris Scoggins,…
Despite the prevalence of diabetes, millions of people who could benefit from the latest medtech management tools are unserved or underserved. Patients who do receive a diagnosis and access to…
WASHINGTON—AdvaMed, the world’s largest trade association representing medtech innovators, today welcomed a letter from U.S. Senators Susan Collins (R-Maine) and Jeanne Shaheen (D-N.H.), co-chairs of the Senate Diabetes Caucus, and…
WASHINGTON—AdvaMed, the MedTech Association®, welcomed today’s CMS’ announcement of the details of the $50 billion Rural Health Transformation Program. This program gives states the chance to access the latest health…
WASHINGTON, D.C.—AdvaMed, the world’s largest trade association representing medtech innovators, today urged the Centers for Medicare and Medicaid Services (CMS) to fix “serious flaws” in its proposed rule to restart…
Thousands of K-12 students returning to school this fall will face a cell phone use ban during instructional hours. Diabetes monitoring deserves an exception.
WASHINGTON, D.C. – In a new op-ed in The Washington Times, Scott Whitaker, president and CEO of AdvaMed, the MedTech Association®, laid out medtech’s vital role in the Trump administration’s…
AdvaMed’s 2024 Medtech Showcase on Capitol Hill featured 37 companies and 40+ innovations, connecting medtech leaders with U.S. policymakers.
AdvaMed’s annual Medtech Showcase and Reception on Capitol Hill seeks to inform a core audience: the members of the Congress and their staff who enact the policies that help our…
South Hamilton, MA – April 7th, 2025 – MedTechVets, a nonprofit dedicated to helping military veterans transition into the medical technology industry, announces its Veteran Placement Partnership with Insulet Corporation (NASDAQ:…